Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)

Clinical trial NCT05461430 · COMPLETED

Trial details

NCT number: NCT05461430
Sponsor: Travera Inc
Status: COMPLETED
Study type: OBSERVATIONAL

Pleural Effusion, Malignant Ascites, Malignant Carcinoma Carcinoma, Hepatocellular Carcinoma, Renal Cell Carcinoma, Renal Carcinoma, Small Cell Carcinoma, Non-Small-Cell Lung Carcinoma, Pancreatic Ductal Carcinoma, Neuroendocrine Carcinoma, Thymic Carcinoma, Pancreatic

Start date: 2022-07-15
Primary completion: 2026-03-23
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.